News | May 07, 2015

Compact Light Source Improves CT Scans

New technology may advance preclinical studies of cancer and other diseases

Compact Light Source, CLS, CT, X-ray, SLAC, Lyncean, Eggl, Pfeiffer, TUM

The Compact Light Source by Palo Alto-based Lyncean Technologies Inc. generates X-rays suitable for advanced tomography. The car-sized device is a miniature version of football-field-sized X-ray generators known as synchrotrons and it emerged from basic research at SLAC in the late 1990s and early 2000s. Image courtesy of Lyncean Technologies Inc.

May 7, 2015 — A new study shows that the recently developed Compact Light Source (CLS), a commercial X-ray source, enables computed tomography (CT) scans that reveal more detail than routine scans performed at hospitals today. With roots in research and development efforts at the Department of Energy’s SLAC National Accelerator Laboratory, the new technology could soon be used in preclinical studies and help researchers better understand cancer and other diseases.

With its ability to image cross sections of the human body, X-ray CT has become an important diagnostic tool in medicine. Conventional CT scans are very detailed when it comes to bones and other dense body parts that strongly absorb X-rays. The technique struggles, however, with the visualization and distinction of “soft tissues” such as organs, which are more transparent to X-rays.

“Our work demonstrates that we can achieve better results with the Compact Light Source,” said Professor for Biomedical Physics Franz Pfeiffer of the Technical University of Munich in Germany, who led the new study published April 20 in the Proceedings of the National Academy of Sciences. “The CLS allows us to do multimodal tomography scans – a more advanced approach to X-ray imaging.”

The amount of detail in a CT scan depends on the difference in brightness, or contrast, which makes one type of tissue distinguishable from another. The absorption of X-rays – the basis for standard CT – is only one way to create contrast.

Alternatively, contrast can be generated from differences in how tissues change the direction of incoming X-rays, either through bending or scattering X-ray light. These techniques are known as phase-contrast and dark-field CT, respectively.

“Organs and other soft tissues don’t have a large absorption contrast, but they become visible in phase-contrast tomography,” said the study’s lead author, Elena Eggl, a researcher at the Technical University of Munich. “The dark-field method, on the other hand, is particularly sensitive to structures like vertebrae and the lung’s alveoli.”

However, these methods require X-ray light with a well-defined wavelength aligned in a particular way – properties that conventional CT scanners in hospitals do not deliver sufficiently.

For high-quality phase-contrast and dark-field imaging, researchers can use synchrotrons – dedicated facilities where electrons run laps in football-stadium-sized storage rings to produce the desired radiation – but these are large and expensive machines that cannot simply be implemented at every research institute and clinic.

Conversely, the CLS is a miniature version of a synchrotron that produces suitable X-rays by colliding laser light with electrons circulating in a desk-sized storage ring. Due to its small footprint and lower cost, it could be operated in almost any location.

“The Large Hadron Collider at CERN is the world’s largest colliding beam storage ring, and the CLS is the smallest,” said SLAC scientist Ronald Ruth, one of the study’s co-authors. Ruth is also chairman of the board of directors and co-founder of Palo Alto-based Lyncean Technologies Inc., which developed the X-ray source based on earlier fundamental research at SLAC. “It turns out that the properties of the CLS are perfect for applications like tomography.”

In the recent study, the researchers reported the first “multimodal” CT scan with the CLS: They recorded all three imaging modes – absorption, phase contrast and dark field – at the same time. Using a total of 361 two-dimensional X-ray images of an infant mouse taken from different directions, the scientists generated cross-section images of the animal.

“The absorption images only show bones and air-filled organs,” Eggl says. “However, the phase-contrast and dark-field images reveal much more detail, showing different organs such as the heart and liver. We can even distinguish different types of fat tissue, which is not possible with absorption-based CT scans.”

Using a standard sample of chemically well-defined liquids, the scientists also demonstrated that they could not only visualize but also quantify differences in their properties – information that can be applied to various body tissues and that is only obtained when combining all three tomography modes.

The success of this research, which was done on a CLS prototype, has led to the commissioning of the first commercial device.

The researchers’ next goal is to use the CLS for phase-contrast and dark-field CT in preclinical studies – an approach that could help visualize cancer. “We work closely together with two clinics to study tumors,” Eggl said. “One of our plans is to image breast tissue samples and also entire breasts after mastectomy to better understand the clinical picture of breast cancer.”

For more information: www.slac.stanford.edu

Related Content

Siemens Healthineers Announces First U.S. Install of Somatom go.Top CT
News | Computed Tomography (CT) | September 17, 2018
September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare
Key Patient Preparations for a CT Scan
News | Computed Tomography (CT) | September 05, 2018
The Center for Diagnostic Imaging (CDI) in Miami recently released a list of important preparations patients should...
Videos | Computed Tomography (CT) | July 25, 2018
A discussion with Patricia Dickson, LRT(CT), director of imaging and outpatient services, Capital Cardiology Associat
Videos | Computed Tomography (CT) | July 23, 2018
Ed Nicol, M.D., FSCCT, MBA, head of cardiac CT, Royal Brompton Hospital, London, and chair of the Society of Cardiova
Videos | Computed Tomography (CT) | July 17, 2018
An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Tri
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
IAC Awards First CT Accreditation for a Mobile Stroke Unit
News | Computed Tomography (CT) | July 09, 2018
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center...
FFR-CT may soon replace invasive angiography for coronary lesion assessment. #EuroPCR 

Anexample of a clinical case of CT-FFR, which can derive the FFR numbers for their entire coronary tree using a noninvasive CT scan.

Feature | Computed Tomography (CT) | May 29, 2018
May 29, 2018 — Results from the innovative SYNTAX III Revolution Trial [1] underline the effectiveness of evolving no
James Min Named Editor-in-Chief of Journal of Cardiovascular Computed Tomography
News | Computed Tomography (CT) | May 01, 2018
James K. Min, M.D., FSCCT, has been selected for a five-year term as the new editor-in-chief of the Journal of...
FDA Clears Siemens' Somatom go.All, go.Top CT Scanners
Technology | Computed Tomography (CT) | April 18, 2018
April 18, 2018 — The U.S.
Overlay Init